Short Interest in Nicox S.A. (OTCMKTS:NICXF) Decreases By 18.2%

Nicox S.A. (OTCMKTS:NICXF) saw a significant decline in short interest in the month of October. As of October 15th, there was short interest totalling 129,700 shares, a decline of 18.2% from the September 30th total of 158,600 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Nicox Price Performance

Shares of OTCMKTS:NICXF remained flat at $0.44 during trading on Wednesday. The company has a 50-day moving average of $0.44 and a 200 day moving average of $0.44. Nicox has a one year low of $0.44 and a one year high of $0.44.

Nicox Company Profile

Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.